121 related articles for article (PubMed ID: 34679256)
81. Tracking of TCR-Transgenic T Cells Reveals That Multiple Mechanisms Maintain Cardiac Transplant Tolerance in Mice.
Miller ML; Daniels MD; Wang T; Wang Y; Xu J; Yin D; Chong AS; Alegre ML
Am J Transplant; 2016 Oct; 16(10):2854-2864. PubMed ID: 27091509
[TBL] [Abstract][Full Text] [Related]
82. IL-17 deficiency attenuates allograft injury and prolongs survival in a murine model of fully MHC-mismatched renal allograft transplantation.
Kwan T; Chadban SJ; Ma J; Bao S; Alexander SI; Wu H
Am J Transplant; 2015 Jun; 15(6):1555-67. PubMed ID: 25824574
[TBL] [Abstract][Full Text] [Related]
83. Role of lentivirus-mediated overexpression of programmed death-ligand 1 on corneal allograft survival.
Nosov M; Wilk M; Morcos M; Cregg M; O'Flynn L; Treacy O; Ritter T
Am J Transplant; 2012 May; 12(5):1313-22. PubMed ID: 22300371
[TBL] [Abstract][Full Text] [Related]
84. Glutamine Administration in Early or Late Septic Phase Downregulates Lymphocyte PD-1/PD-L1 Expression and the Inflammatory Response in Mice With Polymicrobial Sepsis.
Hu YM; Hsiung YC; Pai MH; Yeh SL
JPEN J Parenter Enteral Nutr; 2018 Mar; 42(3):538-549. PubMed ID: 28633555
[TBL] [Abstract][Full Text] [Related]
85. Depletion of PD-1 or PD-L1 did not affect the mortality of mice infected with Mycobacterium avium.
Nakajima M; Matsuyama M; Kawaguchi M; Matsumura S; Kiwamoto T; Matsuno Y; Morishima Y; Yoshida K; Sherpa MT; Yazaki K; Tanaka R; Okiyama N; Muratani M; Ishii Y; Hizawa N
Sci Rep; 2021 Sep; 11(1):18008. PubMed ID: 34504192
[TBL] [Abstract][Full Text] [Related]
86. The role of the PD-1/PD-L1 axis in macrophage differentiation and function during pregnancy.
Zhang Y; Ma L; Hu X; Ji J; Mor G; Liao A
Hum Reprod; 2019 Jan; 34(1):25-36. PubMed ID: 30500923
[TBL] [Abstract][Full Text] [Related]
87. The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo.
Yang J; Riella LV; Chock S; Liu T; Zhao X; Yuan X; Paterson AM; Watanabe T; Vanguri V; Yagita H; Azuma M; Blazar BR; Freeman GJ; Rodig SJ; Sharpe AH; Chandraker A; Sayegh MH
J Immunol; 2011 Aug; 187(3):1113-9. PubMed ID: 21697455
[TBL] [Abstract][Full Text] [Related]
88. Tissue expression of PD-L1 mediates peripheral T cell tolerance.
Keir ME; Liang SC; Guleria I; Latchman YE; Qipo A; Albacker LA; Koulmanda M; Freeman GJ; Sayegh MH; Sharpe AH
J Exp Med; 2006 Apr; 203(4):883-95. PubMed ID: 16606670
[TBL] [Abstract][Full Text] [Related]
89. The natural killer cell activating receptor, NKG2D, is critical to antibody-dependent chronic rejection in heart transplantation.
Lin CM; Gill RG; Mehrad B
Am J Transplant; 2021 Nov; 21(11):3550-3560. PubMed ID: 34014614
[TBL] [Abstract][Full Text] [Related]
90. Novel immunosuppressive effect of FK506 by upregulation of PD-L1 via FKBP51 in heart transplantation.
Luo X; Du G; Chen B; Yan G; Zhu L; Cui P; Dai H; Qi Z; Lan T
Scand J Immunol; 2022 Oct; 96(4):e13203. PubMed ID: 35801698
[TBL] [Abstract][Full Text] [Related]
91. Effect of cold nerve allograft preservation on antigen presentation and rejection.
Ray WZ; Kale SS; Kasukurthi R; Papp EM; Johnson PJ; Santosa KB; Yan Y; Hunter DA; Mackinnon SE; Tung TH
J Neurosurg; 2011 Jan; 114(1):256-62. PubMed ID: 20560721
[TBL] [Abstract][Full Text] [Related]
92. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice.
Wasowska BA; Qian Z; Cangello DL; Behrens E; Van Tran K; Layton J; Sanfilippo F; Baldwin WM
Transplantation; 2001 Mar; 71(6):727-36. PubMed ID: 11330533
[TBL] [Abstract][Full Text] [Related]
93. Monokine induced by interferon-gamma (MIG/CXCL9) is derived from both donor and recipient sources during rejection of class II major histocompatibility complex disparate skin allografts.
Auerbach MB; Shimoda N; Amano H; Rosenblum JM; Kish DD; Farber JM; Fairchild RL
Am J Pathol; 2009 Jun; 174(6):2172-81. PubMed ID: 19389928
[TBL] [Abstract][Full Text] [Related]
94. PD-L1 (B7-H1) Competes with the RNA Exosome to Regulate the DNA Damage Response and Can Be Targeted to Sensitize to Radiation or Chemotherapy.
Tu X; Qin B; Zhang Y; Zhang C; Kahila M; Nowsheen S; Yin P; Yuan J; Pei H; Li H; Yu J; Song Z; Zhou Q; Zhao F; Liu J; Zhang C; Dong H; Mutter RW; Lou Z
Mol Cell; 2019 Jun; 74(6):1215-1226.e4. PubMed ID: 31053471
[TBL] [Abstract][Full Text] [Related]
95. Engineered Small Extracellular Vesicles as a FGL1/PD-L1 Dual-Targeting Delivery System for Alleviating Immune Rejection.
Tsai HI; Wu Y; Liu X; Xu Z; Liu L; Wang C; Zhang H; Huang Y; Wang L; Zhang W; Su D; Khan FU; Zhu X; Yang R; Pang Y; Eriksson JE; Zhu H; Wang D; Jia B; Cheng F; Chen H
Adv Sci (Weinh); 2022 Jan; 9(3):e2102634. PubMed ID: 34738731
[TBL] [Abstract][Full Text] [Related]
96. Intratumoral immunotherapy with anti-PD-1 and TLR9 agonist induces systemic antitumor immunity without accelerating rejection of cardiac allografts.
Dang N; Waer M; Sprangers B; Lin Y
Am J Transplant; 2021 Jan; 21(1):60-72. PubMed ID: 32506732
[TBL] [Abstract][Full Text] [Related]
97. Enhanced tumor control activities of anti-mPD-L1 antibody and antigen-presenting cell-like natural killer cell in an allograft model.
Hung YP; Tu CC; Lai JI; Yang MH; Lee JM; Chao Y
BMC Cancer; 2024 Jan; 24(1):136. PubMed ID: 38279092
[TBL] [Abstract][Full Text] [Related]
98. The cathepsin-S/protease-activated receptor-(PAR)-2 axis drives chronic allograft vasculopathy and is a molecular target for therapeutic intervention.
Ryll M; Lei Y; Thomas MN; Li M; Renz B; Wirth U; Kühn F; Bazhin A; Werner J; Anders HJ; Andrassy J
Transpl Immunol; 2023 Apr; 77():101782. PubMed ID: 36608832
[TBL] [Abstract][Full Text] [Related]
99. Targeting PD-1/PD-L1 inhibits rejection in a heterotopic tracheal allograft model of lung transplantation.
Kaiho T; Suzuki H; Hata A; Matsumoto H; Tanaka K; Sakairi Y; Motohashi S; Yoshino I
Front Pharmacol; 2023; 14():1298085. PubMed ID: 38026994
[TBL] [Abstract][Full Text] [Related]
100. Tissue Expression of Programmed Cell Death 1 Ligand1 (PD-L1) in Biopsies of Transplant Livers of Pediatric Patients as a Possible Marker of Acute Cellular Rejection.
Szymanska S; Markiewicz-Kijewska M; Pyzlak M; Karkucinska-Wienckowska A; Ciopinski M; Czubkowski P; Kaliciński P
J Clin Med; 2023 Jun; 12(13):. PubMed ID: 37445304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
